1.
Braz. j. infect. dis
; Braz. j. infect. dis;19(2): 226-227, Mar-Apr/2015.
Article
in English
| LILACS
| ID: lil-746506
Subject(s)
Humans , HIV Infections/complications , Hepacivirus/genetics , Hepatitis C/drug therapy , Oligopeptides/therapeutic use , Protease Inhibitors/therapeutic use , Coinfection , Genotype , Hepatitis C/complications , Hepatitis C/virology , Oligopeptides/adverse effects , Protease Inhibitors/adverse effects , Treatment Outcome
2.
Braz J Infect Dis
; 19(2): 226-7, 2015.
Article
in English
| MEDLINE
| ID: mdl-25528578
Subject(s)
HIV Infections/complications , Hepacivirus/genetics , Hepatitis C/drug therapy , Oligopeptides/therapeutic use , Protease Inhibitors/therapeutic use , Coinfection , Genotype , Hepatitis C/complications , Hepatitis C/virology , Humans , Oligopeptides/adverse effects , Protease Inhibitors/adverse effects , Treatment Outcome
3.
J Travel Med
; 12(4): 229-31, 2005.
Article
in English
| MEDLINE
| ID: mdl-16086900
ABSTRACT
As tropical countries become common travelers' destinations, more and more returning travelers are expected to present with cutaneous lesions secondary to myiasis. The skin lesion starts as a small red papule and gradually enlarges to become a furuncle. Familiarity with the characteristic clinical presentation and proper management would avoid an unnecessary diagnostic work-up and therapeutic intervention, including surgery and the use of antibiotics.